Susquehanna International Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-384,210
| Closed | -$66.1M | – | 14447 |
|
|
2021
Q3 | $66.1M | Buy |
384,210
+358,022
| +1,367% | +$46.8M | 0.01% | 989 |
|
|
2021
Q2 | $3.29M | Sell |
26,188
-51,250
| -66% | -$6.46M | ﹤0.01% | 4821 |
|
|
2021
Q1 | $10.5M | Buy |
+77,438
| New | +$10M | ﹤0.01% | 2696 |
|
|
2020
Q4 | – | Sell |
-34,150
| Closed | -$4M | – | 11992 |
|
|
2020
Q3 | $3.84M | Sell |
34,150
-35,769
| -51% | -$3.56M | ﹤0.01% | 3446 |
|
|
2020
Q2 | $6.66M | Buy |
69,919
+18,631
| +36% | +$1.8M | ﹤0.01% | 2632 |
|
|
2020
Q1 | $4.61M | Sell |
51,288
-7,140
| -12% | -$555K | ﹤0.01% | 2686 |
|
|
2019
Q4 | $3.1M | Buy |
58,428
+26,061
| +81% | +$1.19M | ﹤0.01% | 3646 |
|
|
2019
Q3 | $1.28M | Sell |
32,367
-27,282
| -46% | -$1.18M | ﹤0.01% | 5164 |
|
|
2019
Q2 | $2.45M | Buy |
+59,649
| New | +$2.47M | ﹤0.01% | 3784 |
|
|
2019
Q1 | – | Sell |
-348,854
| Closed | -$15.3M | – | 10225 |
|
|
2018
Q4 | $15.2M | Buy |
348,854
+114,583
| +49% | +$5.72M | 0.01% | 1262 |
|
|
2018
Q3 | $13.4M | Buy |
+234,271
| New | +$11.5M | ﹤0.01% | 1668 |
|
|
2017
Q1 | – | Sell |
-27,601
| Closed | -$727K | – | 10360 |
|
|
2016
Q4 | $704K | Buy |
+27,601
| New | +$875K | ﹤0.01% | 6269 |
|
|
2016
Q1 | – | Sell |
-11,082
| Closed | -$322K | – | 9911 |
|
|
2015
Q4 | $540K | Buy |
+11,082
| New | +$399K | ﹤0.01% | 6615 |
|
|
2015
Q3 | – | Sell |
-41,119
| Closed | -$1.24M | – | 10421 |
|
|
2015
Q2 | $1.3M | Buy |
+41,119
| New | +$1.33M | ﹤0.01% | 5637 |
|
|
2015
Q1 | – | Sell |
-5,386
| Closed | -$214K | – | 10131 |
|
|
2014
Q4 | $210K | Sell |
5,386
-2,758
| -34% | -$96.1K | ﹤0.01% | 8746 |
|
|
2014
Q3 | $246K | Sell |
8,144
-2,703
| -25% | -$76.1K | ﹤0.01% | 8324 |
|
|
2014
Q2 | $368K | Buy |
+10,847
| New | +$363K | ﹤0.01% | 8039 |
|
Susquehanna International Group's XLRN Position: Q4 2021 in Review
Susquehanna International Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 384,210 shares — an estimated $66.1M sold.
Susquehanna International Group first reported a position in XLRN in Q2 2014 and held it in 17 quarters. The position peaked at $66.1M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Susquehanna International Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Susquehanna International Group sold 384,210 Acceleron Pharma shares in Q4 2021, an estimated $66.1M.
- Susquehanna International Group first reported a position in Acceleron Pharma in Q2 2014 and held it in 17 quarters.
- Susquehanna International Group's Acceleron Pharma position peaked at $66.1M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.